Dosing Penalty of Erythropoiesis-Stimulating Agents After Switching From Originator to Biosimilar Preparations in Stable Hemodialysis Patients.

@article{Minutolo2016DosingPO,
  title={Dosing Penalty of Erythropoiesis-Stimulating Agents After Switching From Originator to Biosimilar Preparations in Stable Hemodialysis Patients.},
  author={Roberto Minutolo and Maurizio Borzumati and Stefano Sposini and Cataldo Abaterusso and Gianni Carraro and Alberto Santoboni and Carlo Mura and Oliviero Filiberti and Domenico Santoro and Romano Musacchio and Patrizio Imperiali and Fulvio Fiorini and Luca De Nicola and Domenico Russo},
  journal={American journal of kidney diseases : the official journal of the National Kidney Foundation},
  year={2016},
  volume={68 1},
  pages={170-2}
}